English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Sanofi

Press release submission | Mar 31, 2021

SANOFI: FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

Press release submission | Feb 28, 2020

SANOFI US: Reaches settlement agreement to resolve allegations related to patient assistance

Trending

Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'

Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas

Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval

+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily